06
Jan
Wuxi
- MSD’s acquisition of the Wuxi Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its footprint to eight locations nationwide with over 3,000 currently employed across the country.
- Together with the acquisition, the company is looking ahead to significant growth across its Irish network, planning to add approximately 1,000 jobs over the coming year, including 150 additional jobs at the newly acquired Dundalk facility.
- The acquisition of the Dundalk facility marks an investment of over €500 million, building on other investments totaling €3 billion in Ireland in the last three years.
As part of its long-term plans in Ireland, MSD has agreed to acquire the Wuxi Vaccines manufacturing facility located in Dundalk, Co Louth. The acquisition signifies an investment of over €500 million, which comes on the back of the company’s recent announcement of a €1 billion investment across its sites in Carlow and Dunboyne, Co Meath, just last year.
MSD and Wuxi will now begin an official handover process which aims to be completed in the first half of 2025.